Trump's Proposed Tariffs on Generic Drug Imports Raise Concerns for India's Pharmaceutical Industry
The US plans to impose a 100 percent tariff on imported generic medicines from August 2028, increasing to 200 percent a year later, prompting Indian drugmakers to reassess export strategies and manufacturing plans.
US Pharmaceutical Tariffs | 23/07/2026 | By News Bureau
Celltrion to Acquire US Biologics Plant to Counter Potential Pharma Tariffs
Celltrion has been selected as the preferred bidder to acquire a large biologics manufacturing plant in the United States —a strategic move aimed at insulating the company from potential US pharmaceutical tariffs.
US Pharmaceutical Tariffs | 30/07/2025 | By Dineshwori | 635
Celltrion Announces Three-Stage Strategy to Counter Trump's Pharma Tariff Plan
Celltrion has announced its response strategy to US President Donald Trump’s plan to impose tariffs on pharmaceuticals.
US Pharmaceutical Tariffs | 10/07/2025 | By Dineshwori | 540
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy